{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:04:38Z","timestamp":1781921078312,"version":"3.54.5"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study examined associations between serum concentrations of per- and polyfluoroalkyl substances (PFASs) and gout risk in the U.S. adult population using the National Health and Nutrition Examination Survey (NHANES) 2007\u20132018 data. And assessing the potential intermediary effect of uric acid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included 8,494 participants, with 385 having gout. Four PFAS compounds (PFOA, PFOS, PFHxS, PFNA) were measured. PFOS is the most prevalent PFAS in the environment, biota, and human tissues. It is rapidly absorbed and accumulates in the liver, kidneys, and blood, binding to serum albumin and low-density lipoprotein. PFOA is highly persistent in the body, mainly accumulating in the kidneys and liver through enterohepatic circulation, posing risks due to its difficulty in metabolism and excretion. PFHxS has the longest metabolic half-life in humans (7.3\u202fyears) and bioaccumulates in the endocrine, immune, nervous, and reproductive systems. PFNA is the second most detected PFAS in human serum after PFOS. It is more likely to accumulate and express toxicity in the reproductive organs, liver, and immune system compared to PFOS and PFOA. Multivariate logistic regression and weighted quantile sum regression were used to assess individual and mixture effects. Mediation analysis was conducted to estimate effect of uric acid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In fully adjusted model, the associations were nonsignificant, with PFOA showing a marginally positive association. Mixture analysis revealed a significant positive association with gout risk across all models. PFOS was the largest contributor to the mixture effect. Stronger associations were observed in old people and females. Sensitivity analyses confirmed the robustness of these findings. Mediation analysis indicated significant intermediary effect of uric acid in the associations of PFAS with risk of gout, with the mediated proportion ranging from 48 to 77%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides evidence for a potential link between PFAS exposure and gout risk, particularly when considering mixtures. While associations with individual PFASs are largely explained by demographic and lifestyle factors, the persistent association of mixtures with gout risk highlights the importance of considering combined exposures in environmental health research. Uric acid level plays a crucial intermediary effect.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1484663","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:51:07Z","timestamp":1739170267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of per- and polyfluoroalkyl substances with gout risk: a cross-sectional analysis of NHANES 2007\u20132018 data emphasizing mixture effects"],"prefix":"10.3389","volume":"13","author":[{"given":"Haixin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhuizi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr Environ Assess Manag"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.1021\/es2011622","article-title":"Polyfluorinated compounds: past, present, and future","volume":"45","author":"Lindstrom","year":"2011","journal-title":"Environ Sci Technol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ Health Perspect"},{"key":"ref5","article-title":"Toxicological effects of Perfluoroalkyl and Polyfluoroalkyl substances","volume-title":"Molecular and Integrative Toxicology","author":"Dewitt","year":"2015"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/ijerph14070691","article-title":"Exposure to Perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature","volume":"14","author":"Rappazzo","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1002502","DOI":"10.1371\/journal.pmed.1002502","article-title":"Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study","volume":"15","author":"Liu","year":"2018","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum Dis Clin N Am"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1289\/ehp.0900940","article-title":"Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA","volume":"118","author":"Steenland","year":"2010","journal-title":"Environ Health Perspect"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e0244815","DOI":"10.1371\/journal.pone.0244815","article-title":"Severity of COVID-19 at elevated exposure to perfluorinated alkylates","volume":"15","author":"Grandjean","year":"2020","journal-title":"PLoS One"},{"key":"ref14","volume-title":"The National Academies Collection: reports funded by National Institutes of Health. Guidance on PFAS exposure, testing, and clinical follow-up","year":"2022"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"077018","DOI":"10.1289\/ehp275","article-title":"Serum vaccine antibody concentrations in adolescents exposed to Perfluorinated compounds","volume":"125","author":"Grandjean","year":"2017","journal-title":"Environ Health Perspect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/aje\/kwp279","article-title":"Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant","volume":"170","author":"Steenland","year":"2009","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chemosphere.2013.10.005","article-title":"The association between PFOA, PFOS and serum lipid levels in adolescents","volume":"98","author":"Geiger","year":"2014","journal-title":"Chemosphere"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/toxsci\/kfq219","article-title":"Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates","volume":"117","author":"Yang","year":"2010","journal-title":"Toxicol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/taap.2001.9159","article-title":"Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid","volume":"173","author":"Panaretakis","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup Environ Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1021\/es401905e","article-title":"Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life","volume":"47","author":"Zhang","year":"2013","journal-title":"Environ Sci Technol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and Polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ Toxicol Chem"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"JAMA"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1484663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:51:10Z","timestamp":1739170270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1484663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":24,"alternative-id":["10.3389\/fpubh.2025.1484663"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1484663","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"article-number":"1484663"}}